A patient with a known history of primary hyperparathyroidism presents with severe, refractory heartburn and chronic watery diarrhea. Endoscopic evaluation performed recently by an outside gastroenterologist demonstrated severe erosive esophagitis and prominent, multiple ulcerations extending into the second and third portions of the duodenum. The patient is currently taking 80 mg of pantoprazole daily with minimal symptom relief. The clinical team strongly suspects a gastrinoma associated with Multiple Endocrine Neoplasia type 1 (MEN1). Arrange the following diagnostic steps in the most appropriate chronological sequence to biochemically confirm the diagnosis and subsequently localize the tumor.
- 1Discontinue proton pump inhibitor therapy and substitute with a histamine-2 receptor antagonist temporarily
- 2Measure simultaneous fasting serum gastrin and gastric pH
- 3Perform an intravenous secretin stimulation test
- 4Obtain a Gallium-68 DOTATATE PET/CT scan
- 5Perform an endoscopic ultrasound (EUS) of the pancreas and duodenum
Cevap
The correct diagnostic sequence begins with discontinuing the proton pump inhibitor, followed by measuring fasting serum gastrin with gastric pH. A secretin stimulation test is then performed to biochemically confirm Zollinger-Ellison syndrome. Once confirmed biochemically, localization is achieved first with a non-invasive Gallium-68 DOTATATE PET/CT, followed by an endoscopic ultrasound.
The diagnostic workup of Zollinger-Ellison syndrome requires a strictly tiered approach, moving from baseline preparation to biochemical confirmation, and finally to anatomical localization. Because proton pump inhibitors cause secondary hypergastrinemia, they must be stopped prior to testing to avoid false-positive results. The initial screening step requires assessing fasting serum gastrin alongside gastric pH to confirm acidic hypergastrinemia. If the gastrin level is elevated but not strongly diagnostic, a secretin stimulation test is required for definitive biochemical confirmation. Only after the biochemical diagnosis is secure should localization studies be pursued. Non-invasive, highly sensitive functional imaging such as a Gallium-68 DOTATATE PET/CT is the initial imaging modality of choice. Finally, endoscopic ultrasound is utilized for precise localization of small tumors within the duodenal wall or pancreas, and for obtaining a required tissue biopsy.
Adım Adım Çözüm
Anahtar Kavram
The diagnostic workup of Zollinger-Ellison syndrome requires securing a definitive biochemical diagnosis (off acid-suppressive therapy) prior to pursuing localization imaging.